# Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

> **NCT00171002** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 936 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan/amlodipine

## Key facts

- **NCT ID:** NCT00171002
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 936 (ACTUAL)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171002, "Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00171002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*